UK Five Year AMR Strategy ( ) Cheshire & Merseyside Health Protection CPD Event Tuesday 19 th November 2013

Transcription

1 UK Five Year AMR Strategy ( ) Tuesday 19 th November 2013

2 Antimicrobial Resistance (AMR) Why AMR: Impact on society The rapid spread of multi-drug resistant (MDR) Many existing antimicrobials are becoming less effective Development of new antibiotics is at an all-time low Requires multiagency / multi-professional and international action It is preventable / avoidable Major contribution to health inequalities e.g., TB, STIs etc. Presentation title - edit in Header and Footer

3 Mission: overarching goal of the Strategy is to slow the development and spread of AMR Focus around 3 strategic aims: 1. Improve the knowledge and understanding of AMR 2. Conserve and steward the effectiveness of existing treatments, and 3. Stimulate the development of new antibiotics, diagnostics and novel therapies.

4 Key documents Annual Report of the Chief Medical Officer Volume Two, 2011: Infections and the rise of antimicrobial Published in March UK Five Year Antimicrobial Resistance Strategy (2013 to 2018) Published in Sept e/244058/ _uk_5_year_amr_strategy.pdf 4

5 Key Recommendations CMO Report Key areas for policy & political action 1. Antimicrobial resistance 2. Surveillance 3. Prevention 4. Education and training of the health and care workforce UK 5 Year AMR The 7 key areas for future action 1. Improving infection prevention and control practices 2. Optimising prescribing practice 3. Professional education, training and public engagement 4. Developing new Antibiotics 5. Surveillance 6. AMR research 7. International collaboration 5

6 Challenges & Opportunities 1. Antimicrobial resistance is increasing worldwide: Put antimicrobial resistance on the national risk register Implement UK cross government AMR Strategy Global leadership and action, around the development of new antibiotics 2. Education and awareness needs to be improved around Antimicrobial resistance, strategies for prevention & antibiotic stewardship, which should be part of routine curricula for all clinical professionals Raising awareness of antimicrobial resistance and appropriate antibiotic use among the public, managers and professionals 6

7 Challenges & Opportunities 3. Surveillance systems - Public Health England and the NHS E Underpin strategies for prevention and antibiotic stewardship Monitor infection monitor antimicrobial (in particular antibiotic) prescribing monitor antimicrobial resistance (AMR) link this information to other Health and Care datasets to inform future action 4. Diagnostic technology for infection Rapid diagnostics that allow movement away from broad spectrum treatments Use of genomic technologies Developments in point of care diagnostics are also particularly important as these have the potential to substantially increase the speed of diagnosis 7

8 Future Challenges 1. Emerging and re-emerging diseases: Microorganism undergoing rapid change e.g., influenza 2. Zoonoses E.g. RNA viruses and SARS epidemic in Climate change The gradual increase of vector range due to climate change effects, and the potential for spread of infectious diseases. There is knowledge gap in this area, not least the indirect impacts of climate change, such as social, political and land-use changes, which can impact on vector distribution. 4. Antimicrobial resistance: the biggest threat that we face today 8